Indian Journal of Ophthalmology

BRIEF COMMUNICATION
Year
: 2012  |  Volume : 60  |  Issue : 4  |  Page : 326--328

Intralesional bleomycin for the treatment of periocular capillary hemangiomas


Derrick P Smit, David Meyer 
 Division of Ophthalmology, Department of Surgical Sciences, Faculty of Health Sciences, University of Stellenbosch, South Africa

Correspondence Address:
David Meyer
Eye Clinic, 7th Floor, Tygerberg Academic Hospital, Francie van Zijl Drive, Tygerberg 7505
South Africa

Periocular infantile capillary hemangiomas do not always respond well to conventional treatment modalities such as systemic or intralesional corticosteroids, radiotherapy or debulking surgery. The authors describe the use of intralesional bleomycin injections (IBIs) to treat potentially amblyogenic lesions in two cases where other modalities have failed. In both cases monthly IBIs successfully cleared the visual axis of the affected eye before the age of 1 year thus preventing permanent sensory deprivation amblyopia. A total of five and nine injections, respectively, were used and no significant side effects were noted. IBI appears to be a useful alternative in the treatment of periocular capillary hemangiomas refractory to more conventional modalities.


How to cite this article:
Smit DP, Meyer D. Intralesional bleomycin for the treatment of periocular capillary hemangiomas.Indian J Ophthalmol 2012;60:326-328


How to cite this URL:
Smit DP, Meyer D. Intralesional bleomycin for the treatment of periocular capillary hemangiomas. Indian J Ophthalmol [serial online] 2012 [cited 2024 Mar 29 ];60:326-328
Available from: https://journals.lww.com/ijo/pages/default.aspx/article.asp?issn=0301-4738;year=2012;volume=60;issue=4;spage=326;epage=328;aulast=Smit;type=0